In an attempt to delineate the basis of the heregulin/neuregulin-β1 (HRG)-triggered invasion of HER2-overexpressing breast cancer cells in late 1996, PAK1 signaling was discovered to play a causative role in mediating the invasiveness of breast cancer cells [19]. Here, HRG is linked to breast carcinoma.